Fabricio Medina‐ Bolivar
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Graduate Student Researcher
Research Areas
Biography and Research Information
OverviewAI-generated summary
Fabricio Medina-Bolivar's research investigates the potential anticancer mechanisms of natural compounds, specifically focusing on prenylated stilbenoids like arachidin-1. His work examines their efficacy as adjuvants for paclitaxel in treating triple-negative breast cancer cells.
Medina-Bolivar has contributed to the scientific community through publications in this area. His research network includes collaborations with Alexx Weaver at the University of Arkansas for Medical Sciences and Linh-Chi Ho at Arkansas State University. He also serves as a Co-Principal Investigator on a National Science Foundation grant that supported the acquisition of a 400 MHz Nuclear Magnetic Resonance (NMR) spectrometer for research at Arkansas State University, an award totaling $345,935.
Metrics
- Publications: 2
Selected Publications
-
Elucidating the Anticancer Mechanism of Arachidin‐1 in Triple‐Negative Breast Cancer Cells (2022)
-
Prenylated Stilbenoids as Potential Adjuvants for Paclitaxel in the Treatment of Triple‐Negative Breast Cancer (2022)
Federal Grants 1 $345,935 total
Collaboration Network
Top Collaborators
- Prenylated Stilbenoids as Potential Adjuvants for Paclitaxel in the Treatment of Triple‐Negative Breast Cancer
- Elucidating the Anticancer Mechanism of Arachidin‐1 in Triple‐Negative Breast Cancer Cells
- Prenylated Stilbenoids as Potential Adjuvants for Paclitaxel in the Treatment of Triple‐Negative Breast Cancer
- Elucidating the Anticancer Mechanism of Arachidin‐1 in Triple‐Negative Breast Cancer Cells
- Prenylated Stilbenoids as Potential Adjuvants for Paclitaxel in the Treatment of Triple‐Negative Breast Cancer
Similar Researchers
Based on overlapping research topics